Xcout IntelAhammune Biosciences
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Subscribe to see Ahammune Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ahammune Biosciences at a glance
Ahammune Biosciences is a drug discovery company headquartered in India. Its most recent funding round, Series A, raised $5M in September 2024. Xcout tracks 10 named people at Ahammune Biosciences, including Dr. Parul Ganju (Co-founder, CEO, Board Member).
Ahammune Biosciences leadership
- Dr. Parul GanjuCo-founder, CEO, Board Member
- Dr Krishnamurthy NatarajanBoard Member, Co-founder
- Krishnamurthy Natarajanco-founder
- Parul Ganjuco-founder
- Dr Mahesh Kumar VermaAssistant Director, Biology
- Dr Sudhanand PrasadDirector, R&D
4 more named people on record for Ahammune Biosciences, with roles, board committees and tenure — see the full roster →
Ahammune Biosciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Ahammune Biosciences competitors
A few of Ahammune Biosciences's closest competitors — see the full list of competitors and alternatives →
AllIn Bio is a drug discovery company headquartered in Woodside, California. The firm is developing a precision-immunology approach designed to treat the root cause of chronic inflammatory diseases.
Baseimmune is a biotechnology research company headquartered in London, United Kingdom, pioneering active immunotherapies. The company combines cutting-edge computational design with advanced protein engineering to develop next-generation vaccines.
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Get Ahammune Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ahammune Biosciences in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access